SCHEMBL1496527

SCHEMBL1496527

OC1CCCC1Oc1ccc(Oc2ccccc2)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPY1R P25929 1/20 0.55
NPY2R P49146 1/20 0.55
NPY4R P50391 1/20 0.55
NPY5R Q15761 1/20 0.55
MMP13 P45452 7/20 0.50
MMP2 P08253 6/20 0.50
MMP9 P14780 5/20 0.43
MMP7 P09237 2/20 0.43
LTA4H P09960 5/20 0.42
NR1H2 P55055 1/20 0.42
BAX Q07812 1/20 0.42
PRKAB2 O43741 1/20 0.42
PRKAG1 P54619 1/20 0.42
PRKAA2 P54646 1/20 0.42
PRKAA1 Q13131 1/20 0.42
PRKAG3 Q9UGI9 1/20 0.42
PRKAG2 Q9UGJ0 1/20 0.42
PRKAB1 Q9Y478 1/20 0.42
TSHR P16473 1/20 0.41
MMP1 P03956 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1496809 0.97 NPY1R (0.59) NPY1RNPY2RNPY4RNPY5RMMP13
SCHEMBL1496812 0.95 NPY1R (0.58) NPY1RNPY2RNPY4RNPY5RMMP13
SCHEMBL1496787 0.93 NPY1R (0.57) NPY1RNPY2RNPY4RNPY5RMMP13
SCHEMBL28570110 0.89 NPY1R (0.62) NPY1RNPY2RNPY4RNPY5RPRKAB2
SCHEMBL1496724 0.89 NPY1R (0.62) NPY1RNPY2RNPY4RNPY5RPRKAB2
SCHEMBL1496715 0.87 NPY1R (0.60) NPY1RNPY2RNPY4RNPY5RPRKAB2
SCHEMBL11503220 0.85 NPY1R (0.54) NPY1RNPY2RNPY4RNPY5RLTA4H
SCHEMBL11568434 0.83 NPY1R (0.53) NPY1RNPY2RNPY4RNPY5RLTA4H
SCHEMBL20022643 0.83 NPY1R (0.73) NPY1RNPY2RNPY4RNPY5RPRKAB2
SCHEMBL11502884 0.82 NPY1R (0.55) NPY1RNPY2RNPY4RNPY5RLTA4H

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101374791-B Method for producing optically active alcohol compound SUMITOMO CO LTD 2012-07-18 CN disclosed
CN-101374792-B Method for producing optically active alcohol compound SUMITOMO CHEMICAL CO 2012-03-28 CN disclosed
US-7906667-B2 Method for producing optically active alcohol compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2011-03-15 US disclosed
US-20100234629-A1 METHOD FOR PRODUCING OPTICALLY ACTIVE ALCOHOL COMPOUND SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-09-16 US disclosed
US-7728179-B2 Method for producing optically active alcohol compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-06-01 US disclosed
EP-1380342-B1 COMPLEX CATALYST, PROCESS FOR PRODUCING THE COMPLEX CATALYST, AND PROCESS FOR PRODUCING ALCOHOL DERIVATIVE WITH THE COMPLEX CATALYST SUMITOMO CHEMICAL CO (JP) 2009-07-01 EP disclosed
US-20090012330-A1 METHOD FOR PRODUCING OPTICALLY ACTIVE ALCOHOL COMPOUND SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-01-08 US disclosed
EP-1982972-A1 METHOD FOR PRODUCING OPTICALLY ACTIVE ALCOHOL COMPOUND Sumitomo Chemical Company, Limited (JP) 2008-10-22 EP disclosed
EP-1982973-A1 METHOD FOR PRODUCING OPTICALLY ACTIVE ALCOHOL COMPOUND Sumitomo Chemical Company, Limited (JP) 2008-10-22 EP disclosed
US-6995110-B2 Complex catalyst, process for producing the complex catalyst, and process for producing alcohol derivative with the complex catalyst SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2006-02-07 US disclosed
US-20040077487-A1 Complex catalyst, process for producing the complex catalyst, and process for producing alchohol derivative with the complex catalyst SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2004-04-22 US disclosed
EP-1380342-A1 COMPLEX CATALYST, PROCESS FOR PRODUCING THE COMPLEX CATALYST, AND PROCESS FOR PRODUCING ALCOHOL DERIVATIVE WITH THE COMPLEX CATALYST SUMITOMO CHEMICAL COMPANY LIMITED (JP) 2004-01-14 EP disclosed
US-4175137-A Etherified cycloalkanols CIBA-GEIGY CORPORATION (US) 1979-11-20 US disclosed
US-4175137-A Etherified cycloalkanols CIBA-GEIGY CORPORATION (US) 1979-11-20 US disclosed
EP-0000506-A3 SUBSTITUTED PHENYL O- OR S- ETHERIFIED CYCLOALKANOLS, A PROCESS FOR THEIR PREPARATION AND THEIR APPLICATION AS HYPOLIPIDEMIA, THEIR ESTERS WITH CYCLOPROPANECARBOXYLIC ACIDS AND THE APPLICATION OF THESE ESTERS AS INSECTICIDES CIBA-GEIGY AG (CH) 1979-06-27 EP disclosed
EP-0000506-A2 Substituted phenyl O- or S- etherified cycloalkanols, a process for their preparation and their application as hypolipidemia, their esters with cyclopropanecarboxylic acids and the application of these esters as insecticides CIBA-GEIGY AG (CH) 1979-02-07 EP disclosed
EP-0000506-A2 Substituted phenyl O- or S- etherified cycloalkanols, a process for their preparation and their application as hypolipidemia, their esters with cyclopropanecarboxylic acids and the application of these esters as insecticides CIBA-GEIGY AG (CH) 1979-02-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090012330-A1 METHOD FOR PRODUCING OPTICALLY ACTIVE ALCOHOL COMPOUND ADH1A, ADH1C, ADH5 NPY1R 1888/4885NPY2R 2780/4885NPY4R 2104/4885
US-20100234629-A1 METHOD FOR PRODUCING OPTICALLY ACTIVE ALCOHOL COMPOUND ADH1A, ADH1C, ADH5 NPY1R 2052/4885NPY2R 3150/4885NPY4R 2769/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.